⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Post-market surveillanceNeuropeptide

Compound 61659

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061659
Risk Class
HIGH
Last Audit
May 29, 2108

Research Abstract

Neuropeptide candidate engineered for cellular repair initiatives with automated dossier coverage.

Compound 61659 is a neuropeptide asset inside neuropeptide innovation track initiatives, optimized for cellular repair and tissue regeneration.

The dossier currently sits in post-market surveillance with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.

Supply records cite CAS AUTO-061659 with updates logged 2108-05-29.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Cellular repairTissue regeneration

Nomenclature

CX-61659Neuropeptide Program 61659

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061659
  2. [2] Operations Pulse • Neuropeptide innovation track
  3. [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61659